XML 24 R14.htm IDEA: XBRL DOCUMENT
v3.20.2

STOCK-BASED COMPENSATION | 6 Months Ended
--- | ---
May 31, 2020
Share-based Payment Arrangement [Abstract] |
STOCK-BASED COMPENSATION |
7. | STOCK-BASED COMPENSATION
| 2017 Plan
| The Company grants stock options and other stock-based awards under its 2017 Stock Option Plan (the “2017 Plan”). All stock option awards granted to employees are valued at fair value by using either the Black-Scholes or Binomial Lattice option pricing models and recognized on a straight-line basis over the service periods of each award. The Company accounts for equity instruments issued in exchange for the receipt of goods or services from non-employees using the estimated fair market value of the consideration received or the estimated fair value of the equity instruments issued, whichever is more reliably measurable. The value of equity instruments issued for consideration for employees and non-employee services is determined on the earlier of a performance commitment or completion of performance by the provider of goods or services.
| During the six months ended May 31, 2020, the Company granted options to purchase 3,917,500 shares of common stock to its employees and directors, of which 3,417,500 options vested immediately and 500,000 options vest over three years. The Company recorded stock-based compensation expense for options granted to its employees and directors of $613,423 and $23,075 during the six months ended May 31, 2020 and 2019, respectively. The Company recorded stock-based compensation expense for options granted to its employees and directors of $11,315 and $18,848 during the three months ended May 31, 2020 and 2019, respectively.
| During the six months ended May 31, 2020, the Company granted options to purchase 110,000 shares of common stock to non-employees (consultants), which vested immediately. The Company recorded stock-based compensation expense for options granted to non-employees of $19,244 and $Nil during the six months ended May 31, 2020 and 2019, respectively. The Company recorded stock-based compensation expense for options granted to non-employees of $19,244 and $Nil during the three months ended May 31, 2020 and 2019, respectively.
| Stock Option Valuation
| The assumptions that the Company used to determine the grant-date fair value of stock options granted to employees and non-employees for the six months ended May 31, 2020 and 2019 were as follows:
| Employee, Director and Non-Employee Options (Black-Scholes option pricing model)
|  | 2020 |  |  | 2019 |
Risk free rate |  |  | 1.07-1.68 | % |  |  | 2.00 | %
Expected dividends |  |  | 0 | % |  |  | 0 | %
Expected volatility |  |  | 143.90-144.28 | % |  |  | 133 | %
Expected life |  |  | 5 years |  |  |  | 5 years |
Market price of the Company’s common stock on date of grant |  | $ | 0.19 |  |  | $ | 0.14 |
Exercise price |  | $ | 0.19 |  |  | $ | 0.14 |
| The following table summarizes option activity under the 2017 Plan during the six months ended May 31, 2020:
|  | Stock |  |  | Weighted-Average Exercise Price Per Stock Option |
|  | Options |  |  | CDN$ |  |  | USD$ |
Outstanding, November 30, 2019 |  |  | 2,911,667 |  |  |  | 0.19 |  |  |  | 0.14 |
Granted |  |  | 4,027,500 |  |  |  | 0.25 |  |  |  | 0.19 |
Expired |  |  | (212,500 | ) |  |  | (0.28 | ) |  |  | (0.21 | )
Cancelled |  |  | — |  |  |  | — |  |  |  | — |
Outstanding, May 31, 2020 |  |  | 6,726,667 |  |  |  | 0.23 |  |  |  | 0.17 |
Exercisable, May 31, 2020 |  |  | 4,726,667 |  |  |  | 0.23 |  |  |  | 0.17 |
| Incentive Warrants
| During the year ended November 30, 2019, the Company issued 750,000 warrants each to two consultants (the “Incentive Warrants”) to purchase common shares. The Incentive Warrants were issued outside of the 2017 Plan and became fully vested in December 2019.
| During the six months ended May 31, 2020, the Company issued 150,000 warrants in exchange for services to a marketing consultant to purchase common shares. The warrants were issued outside of the 2017 Plan and were fully vested at issuance.
| Stock-based compensation expense for the six months ended May 31, 2020 and 2019 was $15,434 and $141,835, respectively. Stock-based compensation expense for the three months ended May 31, 2020 and 2019 was $Nil and $22,395, respectively.
| The assumptions the Company used to determine the grant-date fair value of warrants granted to consultants during the six months ended May 31, 2020 and 2019 were as follows:
| (Black-Scholes option pricing model)
|  | 2020 |  |  | 2019 |
Risk free rate |  |  | 1.47 | % |  |  | 2.00 | %
Expected dividends |  |  | 0 | % |  |  | 0 | %
Expected volatility |  |  | 56.92 | % |  |  | 149 | %
Expected life |  |  | 1.1 years |  |  |  | 3 years |
Market price of the Company’s common stock on date of grant |  | $ | 0.22 |  |  |  | 0.16 |
Exercise price |  | $ | 0.25 |  |  |  | 0.16 |
| Stock-Based Compensation Expense
| Total stock-based compensation expense was $648,101 and $164,910 for the six months ended May 31, 2020 and 2019, respectively. Total stock-based compensation expense was $11,315 and $41,243 for the three months ended May 31, 2020 and 2019, respectively. Total stock-based compensation expense was recorded in SG&A expenses.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration